[Disorders of body water regulation and the therapy--vasopressin antagonists].
Ishikawa
S
S
Saito
T
T
D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D001127:Arginine Vasopressin / Q000627:therapeutic use*; D001552:Benzazepines / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006333:Heart Failure / Q000188:drug therapy; D006727:Hormone Antagonists / Q000627:therapeutic use*; D006801:Humans; D007010:Hyponatremia / Q000188:drug therapy*; D007177:Inappropriate ADH Syndrome / Q000188:drug therapy; D007211:Indoles / Q000627:therapeutic use*; D008106:Liver Cirrhosis, Experimental / Q000188:drug therapy; D011759:Pyrrolidines / Q000627:therapeutic use*
D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines; D006727:Hormone Antagonists; D007211:Indoles; D011759:Pyrrolidines; D001127:Arginine Vasopressin; C076251:mozavaptan; C082134:relcovaptan